Correlation Between Loncar Cancer and Virtus LifeSci
Can any of the company-specific risk be diversified away by investing in both Loncar Cancer and Virtus LifeSci at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Loncar Cancer and Virtus LifeSci into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Loncar Cancer Immunotherapy and Virtus LifeSci Biotech, you can compare the effects of market volatilities on Loncar Cancer and Virtus LifeSci and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Loncar Cancer with a short position of Virtus LifeSci. Check out your portfolio center. Please also check ongoing floating volatility patterns of Loncar Cancer and Virtus LifeSci.
Diversification Opportunities for Loncar Cancer and Virtus LifeSci
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Loncar and Virtus is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Loncar Cancer Immunotherapy and Virtus LifeSci Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virtus LifeSci Biotech and Loncar Cancer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Loncar Cancer Immunotherapy are associated (or correlated) with Virtus LifeSci. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virtus LifeSci Biotech has no effect on the direction of Loncar Cancer i.e., Loncar Cancer and Virtus LifeSci go up and down completely randomly.
Pair Corralation between Loncar Cancer and Virtus LifeSci
Given the investment horizon of 90 days Loncar Cancer Immunotherapy is expected to under-perform the Virtus LifeSci. In addition to that, Loncar Cancer is 1.32 times more volatile than Virtus LifeSci Biotech. It trades about -0.1 of its total potential returns per unit of risk. Virtus LifeSci Biotech is currently generating about 0.05 per unit of volatility. If you would invest 6,476 in Virtus LifeSci Biotech on August 30, 2024 and sell it today you would earn a total of 110.00 from holding Virtus LifeSci Biotech or generate 1.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Loncar Cancer Immunotherapy vs. Virtus LifeSci Biotech
Performance |
| Timeline |
| Loncar Cancer Immuno |
| Virtus LifeSci Biotech |
Loncar Cancer and Virtus LifeSci Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Loncar Cancer and Virtus LifeSci
The main advantage of trading using opposite Loncar Cancer and Virtus LifeSci positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Loncar Cancer position performs unexpectedly, Virtus LifeSci can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virtus LifeSci will offset losses from the drop in Virtus LifeSci's long position.| Loncar Cancer vs. Virtus LifeSci Biotech | Loncar Cancer vs. Virtus LifeSci Biotech | Loncar Cancer vs. ALPS Medical Breakthroughs |
| Virtus LifeSci vs. Virtus LifeSci Biotech | Virtus LifeSci vs. ALPS Medical Breakthroughs | Virtus LifeSci vs. Loncar Cancer Immunotherapy | Virtus LifeSci vs. First Trust NYSE |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |